-
Fluorouracil in Breast and Colon Cancer Research
2026-09-15
Fluorouracil and 5-Fluorouracil are valuable mechanistic probes for studying thymidylate synthase, DNA replication, and treatment-response heterogeneity. This article connects compound handling with the SMC2/SMC4 breast cancer findings to improve assay design and interpretation.
-
UV-Fenton Degradation of Sulfisomidine in Real Water
2026-09-15
The reference study moves beyond parent-drug removal by combining UV-Fenton degradation, HPLC-QTOF-MS transformation-product profiling, QSAR prediction, and HepG2 cytotoxicity testing for sulfisomidine and related pharmaceuticals. Its most important practical finding is that a real DTRO-concentrate matrix slowed degradation and that some intermediates temporarily increased toxicity, demonstrating why treatment assessment must include transformation products rather than disappearance of the starting compound alone.
-
TRIM66 and Monogenic Olfactory Receptor Choice
2026-09-14
The reference study identifies TRIM66 as an epigenetic repressor that helps olfactory sensory neurons transition from low-level expression of multiple receptor genes to stable monogenic receptor expression. Its genetic, molecular, neural-activity, and behavioral evidence connects enhancer repression with olfactory circuit function and innate behavior.
-
ABT-199 and the Next Logic of BCL-2-Dependent Apoptosis
2026-09-14
ABT-199, also known as Venetoclax and GDC-0199, offers a highly selective way to interrogate BCL-2 dependence in apoptosis research. This article connects its mechanistic precision with treatment-induced senescence, hematologic malignancy models, and a translational workflow inspired by glioblastoma research.
-
RNA Pol II Loss and Apoptotic Signaling
2026-09-13
Harper and colleagues show that RNA polymerase II inhibition kills cells through an active apoptotic response to depletion of hypophosphorylated RNA Pol IIA, rather than simply through loss of transcription and progressive mRNA decay. The study defines the Pol II degradation-dependent apoptotic response and provides a framework for interpreting transcription-targeting drugs in cancer research and apoptotic pathway research.
-
Canagliflozin: Interpreting a Negative mTOR Screen
2026-09-12
Canagliflozin hemihydrate is best understood not only as an SGLT2 research tool, but also as a useful negative-control boundary in pathway screening. This article connects renal glucose reabsorption inhibition with a 2025 drug-sensitized yeast study to show how negative mTOR results can improve assay interpretation.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Guide
2026-09-12
Use EZ Cap™ Cy5 EGFP mRNA (5-moUTP) to separate cellular uptake from productive translation in one experiment. Its Cy5 signal supports delivery and trafficking measurements, while EGFP reports functional expression across lipid, nanoparticle, and electroporation workflows.
-
Calnexin Shapes CFTR Variant Rescue
2026-09-11
Tedman et al. used deep mutational scanning to show that calnexin controls CFTR surface expression and corrector responsiveness in a variant- and domain-dependent manner. The study provides a framework for interpreting why the F508del mutation and other clinical CFTR variants differ in pharmacological rescue, while highlighting the need to measure proteostasis and channel function separately.
-
Ceftolozane Sulfate: PK/PD Research Workflows
2026-09-11
Build a translational workflow around Ceftolozane sulfate, from MIC determination and time-kill testing to neutropenic mouse studies and PK/PD modeling. The approach emphasizes AmpC-stable activity, isolate-specific exposure targets, and troubleshooting for resistant Pseudomonas aeruginosa assays.
-
CasKAS: Genome-Wide CRISPR Specificity by ssDNA Mapping
2026-09-10
CasKAS introduces a direct chemical strategy for profiling genome-wide CRISPR binding and cleavage by mapping the single-stranded DNA exposed when sgRNA-loaded Cas9 engages a target. The method extends to both active Cas9 and catalytically inactive dCas9, providing a comparatively accessible way to study off-target specificity in vitro and in cells.
-
T-5224 for AP-1-Driven Inflammation Research
2026-09-10
T-5224 is a selective C-Fos/AP-1 inhibitor for connecting transcription-factor activity with inflammatory, osteoclastogenic, and ferroptosis-related readouts. This practical guide covers model selection, dosing controls, mechanistic validation, and troubleshooting across arthritis research and emerging oncology applications.
-
Bifidobacterium and FMT in Hepatic Encephalopathy
2026-09-09
This 2025 European Journal of Neuroscience study used [18F]PBR146 micro-PET/CT to compare Bifidobacterium and fecal microbiota transplantation in rats with bile duct ligation-induced chronic hepatic encephalopathy. Regional imaging suggested a neuroinflammatory benefit from Bifidobacterium, whereas fecal microbiota transplantation produced no clear positive effect, highlighting the value of spatially resolved molecular imaging for gut-targeted interventions.
-
RIPA Lysis Buffer for EV–Cancer Signaling Workflows
2026-09-09
RIPA Lysis Buffer (Medium) supports reproducible protein extraction from cultured cells and tissue while preserving many degradation- and phosphorylation-sensitive readouts. This workflow translates extracellular-vesicle cancer biology into practical Western blot, immunoprecipitation, ELISA, and signaling-assay sample preparation.
-
Carvedilol: From Receptor Blockade to HCT Strategy
2026-09-08
Carvedilol is more than a cardiovascular research tool. As a β-adrenergic receptor antagonist with α1-adrenergic activity, antioxidant effects, and vascular anti-proliferative properties, it can reveal how sympathetic signaling shapes tissue repair. New transplant findings make receptor selectivity, assay context, and post-HCT timing essential considerations for translational researchers.
-
Carbapenemase Gene Transmission in CREC, Guangdong
2026-09-08
Chen et al. integrated resistance phenotyping, gene-localization assays, conjugation experiments, mobile-element analysis, and ERIC-PCR to characterize carbapenem-resistant Enterobacter cloacae across eight Guangdong teaching hospitals. The study identifies plasmid-associated blaNDM-1 as a major transmission concern and shows why resistance surveillance must distinguish clonal spread from horizontal gene transfer.